TABLE 1.
Frequency of large aggressive events and associated Tavor treatment.
| Age | Treatment | Frequency of large aggressive events per month (average) | Frequency of administrating Tavor per month (average) | |
|---|---|---|---|---|
| 8–13 years old | Neuleptil (4.5 mg daily) | None | None | |
| 13–16 years old | Neuleptil (up to 15 mg daily) | 4 | None | |
| Neuleptil (up to 15 mg daily) + 2.5% CBD oil (0.34 mg CBD/kg bw daily) | None | None | ||
| 16–17 years old | Abilify (7.5 mg daily) + 2.5% CBD oil (0.48 mg CBD/kg bw daily) | 8 | 8 | |
| Abilify (7.5 mg daily) + 2.5% Terpene- enriched CBD oil (0.19 mg CBD/kg bw daily) | 1–2nd months (September–October 2021) | 4 | 4 | |
| 3rd month (November 2021) | 3 | 3 | ||
| 4th month (December 2021) | 2 | 2 | ||
| 5–6th months (January–February 2022) | 0.5 | 0.5 | ||
| 7–9th months (March–April 2022) | None | None | ||